d-Aspartate oxidase (DDO) is a degradative enzyme that is stereospecific for the acidic amino acid d-aspartate, an endogenous agonist of the N-methyl-d-aspartate (NMDA) receptor. Dysregulation of NMDA receptor-mediated neurotransmission has been implicated in the onset of various neuropsychiatric disorders including schizophrenia, as well as chronic pain. Thus, appropriate regulation of d-aspartate is believed to be important for maintaining proper neural activity in the nervous system. Accordingly, much attention has been paid to the role(s) of DDO in the metabolism of d-aspartate in vivo, and the physiological functions of DDO have been actively investigated using experimental rats and mice. However, detailed characterisation of rat DDO has not yet been performed, and little is known about species-specific differences in the properties of mammalian DDOs. In this study, the structural and enzymatic properties of purified recombinant rat, mouse and human DDOs were examined and compared. The results showed that rat DDO is more similar to human DDO than to mouse DDO. This work provides useful insight into the use of rats as an experimental model for investigating the biological significance of human DDO and/or d-aspartate. This article is part of a Special Issue entitled: d-Amino acids: biology in the mirror, edited by Dr. Loredano Pollegioni, Dr. Jean-Pierre Mothet and Dr. Molla Gianluca.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.bbapap.2017.12.009 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Therapeutic potential of D-amino acid oxidase inhibitors for cognitive impairment associated with schizophrenia: learnings from luvadaxistat.
Int J Neuropsychopharmacol
December 2024
Neurocrine Biosciences, Inc., San Diego, CA, United States.
Hypofunction of the N-methyl-D-aspartate receptor (NMDAR) has been proposed to underlie the pathophysiology of schizophrenia, suggesting that promoting NMDAR activity may alleviate the negative or cognitive symptoms associated with schizophrenia. To circumvent excitotoxicity that may accompany direct agonism of the glutamate binding site on the NMDAR, therapeutic trials have focused on targeting the glycine binding site on the NMDAR. Direct administration of either glycine or D-serine, both of which are endogenous coagonists at the NMDAR glycine site, has yielded mixed outcomes across an array of clinical trials investigating different doses or patient populations.
View Article and Find Full Text PDFEffect of D-amino acid metabolic enzyme deficiency on cancer development-diffuse large B-cell lymphoma onset and gene expression analyses in DASPO-knockout mice.
Amino Acids
December 2024
Department of Nephrology and Rheumatology, Kanazawa University, 13-1 Takara-Machi, Kanazawa, 920-8641, Japan.
The relationship between D-AA metabolic enzymes and cancer development remains unclear. We aimed to investigate this relationship using mice deficient in D-AA-related metabolic enzymes. We examined mice lacking these enzymes for approximately 900 days and the effects of altered D-AA metabolism on cancer development based on lifespan, pathological findings, and gene expression.
View Article and Find Full Text PDFUnderstanding the role of potential biomarkers in attenuating multiple sclerosis progression via multiomics and network-based approach.
PLoS One
December 2024
Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, Okhla, New Delhi, India.
Background: Multiple sclerosis (MS) is a complex neurological disorder marked by neuroinflammation and demyelination. Understanding its molecular basis is vital for developing effective treatments. This study aims to elucidate the molecular progression of MS using multiomics and network-based approach.
View Article and Find Full Text PDF[Advances in the Pathophysiology and Drug Discovery of Novel Therapeutics for Attention-Deficit/hyperactivity Disorder].
Yakugaku Zasshi
December 2024
Department of Pharmacology, Faculty of Pharmaceutical Science, Health Sciences University of Hokkaido.
Article Synopsis
- ADHD is a neurodevelopmental disorder marked by inattention, hyperactivity, and impulsivity, typically treated with psychostimulants like methylphenidate, which have significant side effects and addiction risks.
- * The study used juvenile stroke-prone spontaneously hypertensive rats (SHRSP/Ezo) to explore D-serine levels and NMDA receptor dysfunction in relation to ADHD, finding a lower D-serine/total serine ratio in these rats compared to control rats.
- * Inhibiting DAAO in the mPFC improved the D-serine levels and reduced ADHD-like behaviors in SHRSP/Ezo, suggesting that D-serine metabolism may play a key role in ADHD's pathogenesis and pointing towards potential new treatments
NMDA receptor blockade attenuates Japanese encephalitis virus infection-induced microglia activation.
J Neuroinflammation
November 2024
Department of Medical Research, Taichung Veterans General Hospital, No. 1650, Sec. 4, Taiwan Boulevard, Taichung City, 407, Taiwan.
Article Synopsis
- Neurodegeneration and neuroinflammation play significant roles in Japanese Encephalitis virus (JEV) infection, with the NMDA receptor contributing to these processes through excitatory neurotoxicity and inflammation.
- Research showed that JEV infection in rat microglia leads to glutamate release, activating harmful signaling pathways that result in pro-inflammatory responses and neurodegeneration.
- NMDA receptor antagonists, such as MK801 and memantine, were found to reduce the harmful effects of JEV infection on microglia and neurons, indicating their potential as therapeutic options to mitigate neuroinflammation and cell death.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!